Sarosiek S, Doughty C, Castillo J
Curr Hematol Malig Rep. 2024; 20(1):2.
PMID: 39680359
DOI: 10.1007/s11899-024-00745-8.
Treon S, Sarosiek S, Castillo J
Blood. 2024; 143(17):1702-1712.
PMID: 38211337
PMC: 11103089.
DOI: 10.1182/blood.2022017235.
Fuchida S, Ogura M, Ishida T, Hata H, Handa H, Katoh N
Int J Hematol. 2023; 118(4):443-449.
PMID: 37515656
DOI: 10.1007/s12185-023-03647-2.
Palladini G, Milani P
Drugs. 2023; 83(3):203-216.
PMID: 36652193
DOI: 10.1007/s40265-022-01830-z.
Gustine J, Szalat R, Staron A, Joshi T, Mendelson L, Sloan J
Haematologica. 2022; 108(6):1680-1684.
PMID: 36546447
PMC: 10230421.
DOI: 10.3324/haematol.2022.282264.
A Focus on Waldenström Macroglobulinemia and AL Amyloidosis.
Lu R, Richards T
J Adv Pract Oncol. 2022; 13(Suppl 4):45-56.
PMID: 35937468
PMC: 9342921.
DOI: 10.6004/jadpro.2022.13.5.14.
IgM monoclonal gammopathies of clinical significance: diagnosis and management.
Khwaja J, DSa S, Minnema M, Kersten M, Wechalekar A, Vos J
Haematologica. 2022; 107(9):2037-2050.
PMID: 35770530
PMC: 9425303.
DOI: 10.3324/haematol.2022.280953.
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.
Girard L, Soekojo C, Ooi M, Chng W, De Mel S
Front Oncol. 2022; 12:905484.
PMID: 35756635
PMC: 9219578.
DOI: 10.3389/fonc.2022.905484.
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).
Zerdan M, Valent J, Diacovo M, Theil K, Chaulagain C
Adv Hematol. 2022; 2022:1182384.
PMID: 35096069
PMC: 8791721.
DOI: 10.1155/2022/1182384.
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.
Treon S, Xu L, Guerrera M, Jimenez C, Hunter Z, Liu X
J Clin Oncol. 2020; 38(11):1198-1208.
PMID: 32083995
PMC: 7351339.
DOI: 10.1200/JCO.19.02314.
Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives.
Sarosiek S, Sanchorawala V
J Blood Med. 2019; 10:373-380.
PMID: 31695543
PMC: 6815750.
DOI: 10.2147/JBM.S183857.
